TY - JOUR
T1 - The Role of Oxidative Stress, Inflammation, and Advanced Glycation End Product in Skin Manifestations of Diabetes Mellitus
AU - Legiawati, Lili
N1 - Funding Information:
The authors would like to thank Universitas Indonesia for funding this research through PUTI Grant with contract number NKB-1895/UN2.RST/HKP.05.00/2020.
Funding Information:
The publication of this study is funded by PUTI Grant with contract number NKB-1895/UN2.RST/HKP.05.00/ 2020.
Publisher Copyright:
© 2022 Bentham Science Publishers.
PY - 2022/3
Y1 - 2022/3
N2 - Diabetes mellitus is a metabolic disorder caused by an increase in insulin resistance, a decrease in insulin production, or both of them, resulting in a high level of blood glucose or hyper-glycemia. An uncontrolled state of DM may cause complications, namely skin disorder. One or more skin disorders are found amongst 74% of T2DM patients, with the highest percentage is dry skin (47%), followed by infection (10%), diabetic hand (5%), hair loss and diabetic dermopathy (each 4%). In DM, the state of hyperglycemia and production of advanced glycaemic end-products (AGEs) profoundly impact skin changes. In the pathological pathway, AGEs induce oxidative stress and inflammation. Nonetheless, AGEs level is higher in T2DM patients compared to non-T2DM people. This is caused by hyperglycemia and oxidative stress. Binding between AGEs and receptor of AGEs (RAGE) promotes pathway of oxidative stress and inflammation cascade via mi-togen-activated protein kinases (MAPK), nuclear factor-k-light-chain-enhancer of activated β cells (NF-kβ), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 2 (VCAM-2) pathway which fur-therly effectuates DM complication including skin disorders.
AB - Diabetes mellitus is a metabolic disorder caused by an increase in insulin resistance, a decrease in insulin production, or both of them, resulting in a high level of blood glucose or hyper-glycemia. An uncontrolled state of DM may cause complications, namely skin disorder. One or more skin disorders are found amongst 74% of T2DM patients, with the highest percentage is dry skin (47%), followed by infection (10%), diabetic hand (5%), hair loss and diabetic dermopathy (each 4%). In DM, the state of hyperglycemia and production of advanced glycaemic end-products (AGEs) profoundly impact skin changes. In the pathological pathway, AGEs induce oxidative stress and inflammation. Nonetheless, AGEs level is higher in T2DM patients compared to non-T2DM people. This is caused by hyperglycemia and oxidative stress. Binding between AGEs and receptor of AGEs (RAGE) promotes pathway of oxidative stress and inflammation cascade via mi-togen-activated protein kinases (MAPK), nuclear factor-k-light-chain-enhancer of activated β cells (NF-kβ), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 2 (VCAM-2) pathway which fur-therly effectuates DM complication including skin disorders.
KW - Advanced glycation end-products
KW - diabetes mellitus
KW - inflammation
KW - NF-kβ
KW - oxidative stress
KW - TNF-α
UR - http://www.scopus.com/inward/record.url?scp=85128485186&partnerID=8YFLogxK
U2 - 10.2174/1573399817666210920102318
DO - 10.2174/1573399817666210920102318
M3 - Article
C2 - 34544349
AN - SCOPUS:85128485186
SN - 1573-3998
VL - 18
SP - 87
EP - 92
JO - Current Diabetes Reviews
JF - Current Diabetes Reviews
IS - 3
M1 - e200921196637
ER -